Literature DB >> 30527430

Update on the epidemiology and disease outcome of Familial Mediterranean fever.

Seza Özen1.   

Abstract

Autoinflammatory diseases (AIDs) are diseases of the innate immune system, with clinical and laboratory evidence of attacks of inflammation. The more common AIDs are those associated with periodic fevers: Familial Mediterranean fever (FMF); Mevalonate Kinase Deficiency (MKD)/Hyperimmunoglobulin D Syndrome (HIDS); Cryopyrin-associated Autoinflammatory Syndrome (CAPS); and Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS). Classification criteria have been developed for all these types. FMF is the most common AID worldwide with a particularly high prevalence in the Eastern Mediterranean region. Environmental factors are thought to affect the course of the disease. Outcome measures are being developed for AIDs.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoinflammatory diseases; Epidemiology; Familial Mediterranean fever

Mesh:

Year:  2018        PMID: 30527430     DOI: 10.1016/j.berh.2018.09.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  6 in total

1.  Follow the complex bread crumbs: A review of autoinflammation for the general paediatrician.

Authors:  Paul Tsoukas; Ronald M Laxer
Journal:  Paediatr Child Health       Date:  2019-07-18       Impact factor: 2.253

2.  Familial mediterranean fever: assessment of clinical manifestations, pregnancy, genetic mutational analyses, and disease severity in a national cohort.

Authors:  Hatice Bodur; Fatma Gül Yurdakul; Hasan Fatih Çay; Ülkü Uçar; Yaşar Keskin; Betül Sargın; Gülcan Gürer; Ozan Volkan Yurdakul; Mustafa Çalış; Hülya Deveci; Yıldıray Aydın; Sami Hizmetli; Remzi Çevik; Ali Yavuz Karahan; İsmihan Sunar; Mehmet Tuncay Duruöz; Hilal Ecesoy; Zafer Günendi; Murat Toprak; Nesrin Şen; Duygu Altıntaş; Ahmet Kıvanç Cengiz; Gökhan Çağlayan; Ali Nail Demir; Hüseyin Kaplan; Sertaç Ketenci; Meltem Alkan Melikoğlu; Mehmet Nayimoğlu; Kemal Nas; Ayşe Banu Sarıfakıoğlu; İlhan Sezer
Journal:  Rheumatol Int       Date:  2019-09-14       Impact factor: 2.631

Review 3.  Programmed Cell Death in the Evolutionary Race against Bacterial Virulence Factors.

Authors:  Carolyn A Lacey; Edward A Miao
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-02-03       Impact factor: 10.005

4.  A gene expression map of host immune response in human brucellosis.

Authors:  Ioannis Mitroulis; Akrivi Chrysanthopoulou; Georgios Divolis; Charalampos Ioannidis; Maria Ntinopoulou; Athanasios Tasis; Theocharis Konstantinidis; Christina Antoniadou; Natalia Soteriou; George Lallas; Stella Mitka; Mathias Lesche; Andreas Dahl; Stephanie Gembardt; Maria Panopoulou; Paschalis Sideras; Ben Wielockx; Ünal Coskun; Konstantinos Ritis; Panagiotis Skendros
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

5.  Real-life data on tapering or discontinuation of canakinumab therapy in patients with familial Mediterranean fever.

Authors:  Yusuf Karabulut; Halise Hande Gezer; Nuran Öz; İrfan Esen; Mehmet Tuncay Duruöz
Journal:  Rheumatol Int       Date:  2022-09-01       Impact factor: 3.580

6.  [Results of the systematic literature search as basis for the "Evidence-based treatment recommendations for familial Mediterranean fever patients with insufficient response or intolerability to colchicine" of the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].

Authors:  T Sahr; U Kiltz; C Weseloh; T Kallinich; J Braun
Journal:  Z Rheumatol       Date:  2020-09-30       Impact factor: 1.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.